wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41719274-6F8F08AC-B30B-486A-A895-21E9F0F0D261
Q41719274-6F8F08AC-B30B-486A-A895-21E9F0F0D261
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41719274-6F8F08AC-B30B-486A-A895-21E9F0F0D261
Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579).
P2860
Q41719274-6F8F08AC-B30B-486A-A895-21E9F0F0D261
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41719274-6F8F08AC-B30B-486A-A895-21E9F0F0D261
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77b2b1e839e52d2bc307b62e40d902e2efb15c1c
P2860
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105